Tumor-associated macrophages promote tumor cell proliferation in nasopharyngeal NK/T-cell lymphoma

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 9, 2014, Pages 5429-5435

  Liu, Yixiong ^a   Fan, Linni ^a   Wang, Yingmei ^a   Li, Peifeng ^a   Zhu, Jin ^a   Wang, Lu ^a   Zhang, Weichen ^a   Zhang, Yuehua ^a   Huang, Gaosheng ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

CD163; CD68; Ki 67 label index; NK T cell lymphoma; Tumor associated macrophages (TAMs)

Indexed keywords

CD163 ANTIGEN; CD68 ANTIGEN, HUMAN; CELL SURFACE RECEPTOR; DIFFERENTIATION ANTIGEN; KI 67 ANTIGEN; LEUKOCYTE ANTIGEN; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; BIOPSY; CELL COMMUNICATION; CELL PROLIFERATION; CHEMISTRY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; IMMUNOPHENOTYPING; MACROPHAGE; MALE; MIDDLE AGED; NASOPHARYNX TUMOR; NK T CELL LYMPHOMA; PATHOLOGY; PRESCHOOL CHILD; TUMOR MICROENVIRONMENT; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BIOMARKERS, TUMOR; BIOPSY; CELL COMMUNICATION; CELL PROLIFERATION; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; KI-67 ANTIGEN; LYMPHOMA, EXTRANODAL NK-T-CELL; MACROPHAGES; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; RECEPTORS, CELL SURFACE; TUMOR MICROENVIRONMENT;

EID: 84911482696     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Zhou DM, Chen G, Zheng XW, Li C and He YZ. Clinicopathologic analysis of 7 cases of primary cutaneous NK/T cell lymphoma, nasal type. Zhonghua Bing Li Xue Za Zhi 2011; 40: 772-773.
2. Barcellos-Hoff MH, Park C and Wright EG. Radiation and the microenvironment - tumorigenesis and therapy. Nat Rev Cancer 2005; 5: 867-875.
3. Qian BZ and Pollard JW. Macrophage diversity enhances tumor progression and metastasis. Cell 2010; 141: 39-51.
4. Solinas G, Germano G, Mantovani A and Allavena P. Tumor-associated macrophages (TAM) as major players of the cancer-related infammation. J Leukoc Biol 2009; 86: 1065-1073.
5. Erreni M, Mantovani A and Allavena P. Tumorassociated Macrophages (TAM) and Infammation in Colorectal Cancer. Cancer Microenviron 2011; 4: 141-154.
6. Ishigami S, Natsugoe S, Tokuda K, Nakajo A, Okumura H, Matsumoto M, Miyazono F, Hokita S and Aikou T. Tumor-associated macrophage (TAM) infltration in gastric cancer. Anticancer Res 2003; 23: 4079-4083.
7. Jonjic N, Valkovic T, Lucin K, Iternicka Z, Krstulja M, Mustac E, Dobi-Babic R, Sasso F and Melato M. Comparison of microvessel density with tumor associated macrophages in invasive breast carcinoma. Anticancer Res 1998; 18: 3767-3770.
8. Elaine Jaffe NCI, Bethesda, MD. 20892-1500, USA. Nancy Lee Harris, Massachusetts General Hospital, Boston, MA, USA. Harald Stein, Universitatsklinikum Benjamin Franklin, 12200 Berlin, Germany. Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues (World Health Organization Classifcation of Tumours) Intl Agency for Research on Cancer July 7, 2003.
9. Paton D, Faragher B, Mustaffa KM, Szestak T, Barrett SD and Craig AG. Automated counting for Plasmodium falciparum cytoadherence experiments. Malar J 2011; 10: 91.
10. Swartz MA, Iida N, Roberts EW, Sangaletti S, Wong MH, Yull FE, Coussens LM and Declerck YA. Tumor Microenvironment Complexity: Emerging Roles in Cancer Therapy. Cancer Res 2012; 72: 2473-80.
11. Stokes JB, Adair SJ, Slack-Davis JK, Walters DM, Tilghman RW, Hershey ED, Lowrey B, Thomas KS, Bouton AH, Hwang RF, Stelow EB, Parsons JT and Bauer TW. Inhibition of focal adhesion kinase by PF-562,271 inhibits the growth and metastasis of pancreatic cancer concomitant with altering the tumor microenvironment. Mol Cancer Ther 2011; 10: 2135-2145.
12. Zhou J, Mauerer K, Farina L and Gribben JG. The role of the tumor microenvironment in hematological malignancies and implication for therapy. Front Biosci 2005; 10: 1581-1596.
13. Lee HO, Silva AS, Concilio S, Li YS, Slifker M, Gatenby RA and Cheng JD. Evolution of tumor invasiveness: the adaptive tumor microenvironment landscape model. Cancer Res 2011; 71: 6327-6337.
14. Tarin D. Clinical Biological Implications of the Tumor Microenvironment. Cancer Microenviron 2012; 5: 95-112.
15. Mantovani A, Germano G, Marchesi F, Locatelli M and Biswas SK. Cancer-promoting tumorassociated macrophages: new vistas and open questions. Eur J Immunol 2011; 41: 2522-2525.
16. Schmieder A, Michel J, Schonhaar K, Goerdt S and Schledzewski K. Differentiation and gene expression profle of tumor-associated macrophages. Semin Cancer Biol 2012; 22: 289-97.
17. Baay M, Brouwer A, Pauwels P, Peeters M and Lardon F. Tumor cells and tumor-associated macrophages: secreted proteins as potential targets for therapy. Clin Dev Immunol 2011; 2011: 565187.
18. Ohri CM, Shikotra A, Green RH, Waller DA and Bradding P. Macrophages within NSCLC tumour islets are predominantly of a cytotoxic M1 phenotype associated with extended survival. Eur Respir J 2009; 33: 118-126.
19. Shabo I and Svanvik J. Expression of macrophage antigens by tumor cells. Adv Exp Med Biol 2011; 714: 141-150.
20. Harris JA, Jain S, Ren Q, Zarineh A, Liu C and Ibrahim S. CD163 versus CD68 in tumor associated macrophages of classical hodgkin lymphoma. Diagn Pathol 2012; 7: 12.
21. Nakagawa J, Saio M, Tamakawa N, Suwa T, Frey AB, Nonaka K, Umemura N, Imai H, Ouyang GF, Ohe N, Yano H, Yoshimura S, Iwama T and Takami T. TNF expressed by tumor-associated macrophages, but not microglia, can eliminate glioma. Int J Oncol 2007; 30: 803-811.
22. Mantovani A and Sica A. Macrophages, innate immunity and cancer: balance, tolerance, and diversity. Curr Opin Immunol 2010; 22: 231-2 3 7.
23. Feng HC, Song YF and Wen YM. [Correlation between expression of vascular endothelial growth factor-C in tumor-associated macrophages and lymphatic metastasis in oral cancer]. Ai Zheng 2004; 23: 278-281.
24. Hemmerlein B, Markus A, Wehner M, Kugler A, Zschunke F and Radzum HJ. Expression of acute and late-stage infammatory antigens, cfms, CSF-1, and human monocytic serine esterase 1, in tumor-associated macrophages of renal cell carcinomas. Cancer Immunol Immunother 2000; 49: 485-492.
25. Sica A. Role of tumour-associated macrophages in cancer-related infammation. Exp Oncol 2010; 32: 153-158.
26. Yuan A, Chen JJ and Yang PC. Pathophysiology of tumor-associated macrophages. Adv Clin Chem 2008; 45: 199-223.
27. Ishii H, Takahara M, Nagato T, Kis LL, Nagy N, Kishibe K, Harabuchi Y and Klein E. Monocytes enhance cell proliferation and LMP1 expression of nasal natural killer/T-cell lymphoma cells by cell contact-dependent interaction through membrane-bound IL-15. Int J Cancer 2012; 130: 48-58.